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1. Introduction 
Selective toxicity of alloxan towards the pancre- 
atic B-cell can be explained by the coincidence of 
two biochemical features: the capacity of alloxan to 
accumulate rapidly into the B-cell [ 1,2]; and the high 
sensitivity of the B-cell towards peroxides (unpub- 
lished). In other tissues, either alloxan does not enter 
rapidly into the cell (e.g., in muscle) or the activity of 
enzymes involved in the reduction of peroxides is suf- 
ficiently high to ensure resistance against these agents 
(e.g., in liver). 
Guinea pigs are more resistant than rats towards 
the diabetogenic action of alloxan [3]. Here, we have 
investigated whether this species difference could be 
accounted for by a difference in sensitivity of pan- 
creatic islets removed from guinea pigs and rats, 
respectively, towards t-butyl hydroperoxide. 
2. Materials and methods 
Pancreatic islets were isolated by the collagenase 
method [4] from fed guinea pigs or albino rats. 
Groups of 10-l 5 islets each were preincubated for 
30 min at 37°C in 30 ~1 bicarbonate-buffered 
medium [5] containing bovine albumin (5 mg/ml), 
D-glucose (11 .l mM) and, as required, tert-butyl 
hydroperoxide (0.005-2.0 mM; Aldrich-Europe, 
Beerse). The preincubation medium was then brought 
to 60 ~1 by addition of an identical medium enriched 
with D- [U-‘4C] glucose (10 /.&i/ml). The oxidation of 
glucose was measured as in [6] over 60 min incuba- 
tion at 37°C and expressed as pmol . h-’ . islet-‘. 
The statistical significance of differences between 
mean values was assessed by use of the Student’s 
f-test. 
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3. Results 
In the absence of t-butyl hydroperoxide, the oxi- 
dation of D-[U-14C]glucose (11 .l mM) was not sig- 
nificantly different in rat and guinea pig islets, averag- 
ing, respectively, 28.7 f 1.2 (n = 34) and 23.9 + 3.4 
(n = 11) pmol . h-’ . islet -I. Up to 0.1 mM, t-butyl 
peroxide failed to significantly affect glucose oxida- 
tion by rat islets (fig.1). At higher concentrations 
(0.02-2.0 mM), t-butyl peroxide caused a dose-related 
inhibition of glucose oxidation by rat islets. Guinea 
c 40r 
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Fig.1. Effect of increasing concentrations of t-butyl hydro- 
peroxide (logarithmic scale) upon the oxidationof D-[U-‘4C]- 
glucose by islets of rats (o-0) and guinea pigs (o---o). 
Mean values (GEM) refer to lo-34 individual measure- 
ments. In each species, the horizontal lines were drawn at the 
mean level derived from all sets of data which were not sig- 
nificantly different from one another. 
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pig islets were more resistant than rat islets to t-butyl 
peroxide. For instance, at 0.5 mM, t-butyl peroxide 
failed to significantly affect glucose oxidation by 
guinea pig islets and virtually abolished oxidation in 
rat islets. Thus, relative to the mean control value, the 
rate of glucose oxidation in the presence of 0.5 mM 
t-butyl peroxide averaged 104.6 + 12.1% (YZ = 13) and 
9.1 f 3.1% (n = 10) in guinea pig and rat islets, 
respectively (P < 0.001). The dose-action relation- 
ship suggested that guinea pig islets are -5times 
more resistant than rat islets towards t-butyl hydro- 
peroxide (fig.1). 
4. Discussion 
It is thought that the cytotoxic effect of alloxan is 
related to the generation of reactive compounds such 
as hydrogen peroxide, superoxide anion radicals and 
hydroxyl radicals [7-91. However, the selectivity of 
the cytotoxic effect of alloxan towards the pancreatic 
B-cell remained so far unexplained. In the rat, using 
t-butyl hydroperoxide as substrate, glutathione per- 
oxidase activity was found to be much lower in islets 
than in such tissues as liver, kidney or exocrine pan- 
creas [lo]. To assess the functional significance of 
this finding, we investigated whether the difference in 
enzymatic activity was reflected by a difference in 
the sensitivity towards exogenous peroxides: We 
examined the influence of t-butyl hydroperoxide 
upon D-[U-‘4C]glucose oxidation by several tissues. 
t-Butyl hydroperoxide was used instead of alloxan, 
on the assumption that the entry of the former drug 
into the cell would not display any marked tissue 
specificity, in contrast to alloxan which, shortly after 
its injection in vivo, accumulates preferentially in such 
tissues as liver and pancreatic islets [2,1 1,121. Using 
glucose oxidation as an indicator of the sensitivity of 
intact cells towards t-butyl hydroperoxide, we 
observed, in good agreement with the enzymic data, 
that islets were much less resistant to peroxide than 
other tissues (unpublished). This study indicates that 
the lesser sensitivity of guinea pigs, as distinct from 
rats, towards the diabetogenic action of alloxan [3] 
coincides with a lesser sensitivity of the pancreatic 
islets towards t-butyl hydroperoxide. Thus, this find- 
ing supports the view that the selective toxicity of 
alloxan towards the pancreatic B-cell is attributable, 
in addition to the cellular uptake of the drug, to the 
poor capacity of islet cells to protect themselves 
against the deleterious effects of peroxides. 
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